Global Therapeutic Area Head, Respiratory, Immunology

Job Title: Global Therapeutic Area Head, Respiratory, Immunology

Location: Cambridge, MA

About the Job

Reporting to the Global Head of Immunology and as a member of the Immunology Franchise Leadership Team (IFLT), lead the Global Respiratory Immunology TA with responsibility to take assets from PoCC to Wave 1 launches.

Key Assets: Lunsekimig, Amlitelimab, Rilzabrutnib

Disease Areas: Asthma, COPD, CRSwNP, Bronchiectasis, IPF, ILD

We are an innovative global healthcare company, committed to transforming the lives of people with immune challenges, rare diseases and blood disorders, cancers, and neurological disorders. From R&D to sales, our talented teams work together, revolutionizing treatment, continually improving products, understanding unmet needs, and connecting communities. We chase the miracles of science every single day, pursuing progress to make a real impact on millions of patients around the world.​

Main Responsibilities:

• Develop Disease Area strategy and co-positioning narrative of multiple assets in the same disease area that maximizes value for Sanofi.

• Oversee market development / shaping strategy, pre-launch and launch plans for assets with partnership of Wave 1 countries and Global Brand Teams

• Direct the institutional learning and market shaping around an asset or in a new disease area by commissioning rapid and appropriate insights work, connecting with KOLs and patient advocacy groups and leaders

• Working with SILC LEx, create the preparedness required for a successful launch by ensuring rigorous launch readiness management, lead effective launch readiness reviews with senior management updating them on progress, and being vocal about barriers and opportunities

• Own Global P&L and oversee strategic and financial planning for brands, developing sales and expense forecasts to maximize value

• Lead vision & strategy development for launch brands and provide strategic leadership to Global Brand Teams (GBT) for Rilzabrutnib, Amlitelimab, and Lunsekimig covering value & access, patient advocacy, medical, and commercial activities in collaboration with US and key markets for the brands

• Following the successful launch in Wave 1 markets, mobilize TA BLs/IBLs and GBTs to continue supporting Wave 2+ country launches

• Actively partner with global project teams and NPP teams to provide robust commercial direction on pipeline planning and product development strategy

• Support the program teams directly and/or through the NPP team throughout the governance process (TARC, DWG, IDCC) providing TA business leadership within the franchise, R&D and investment committees.

• Understand and communicate requirements for regulatory approval (registration), access to market (pricing & reimbursement), and market differentiation required for the successful commercialization of new products.

• Partner with NPP, business development and related M&A teams to ensure the BD roadmap remains in-line with TA strategy and evaluate potential commercial synergies with TA portfolio. 

• Build and develop a best-in-class team, and foster strong coordination across functions

About You

Experience & Qualifications:

• Bachelor’s Degree required (MBA, MS or PhD in life science preferred)

• Extensive and diverse industry experience: A minimum of 10 years of professional experience in the pharmaceutical industry, across various functions (e.g., sales, marketing, MA, BD, NPP, etc.), including in US/key markets, with a focus on Respiratory Immunology and related therapeutic areas (e.g., in-depth knowledge of key stakeholders / influencers / competitors (required)

• Leadership and brand manag